CymaBay Therapeutics Inc. (CBAY) earnings
Quarterly and annual CBAY reports and results, each read against the price at its own news timestamp. Back to the CBAY overview →
2 measured CBAY earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K CymaBay Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.15% | -0.28% | |
| Form 10-Q CymaBay Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.80% | -4.27% |
Keep exploring
More CBAY: analyst actions → · SEC filings → · CBAY overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | 167 | -0.32% | 42% |
| Boundless Bio, Inc. (BOLD) | 166 | -0.48% | 44% |
| Innoviva, Inc. (INVA) | 166 | +0.10% | 54% |
| MediWound Ltd. - Ordinary Shares (MDWD) | 166 | +0.11% | 53% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.